113.08
1.56%
1.74
前日終値:
$111.34
開ける:
$110.76
24時間の取引高:
863.98K
Relative Volume:
1.05
時価総額:
$27.11B
収益:
$3.30B
当期純損益:
$-501.07M
株価収益率:
9.8003
EPS:
11.5384
ネットキャッシュフロー:
$1.03B
1週間 パフォーマンス:
-6.06%
1か月 パフォーマンス:
+10.71%
6か月 パフォーマンス:
+31.67%
1年 パフォーマンス:
+10.00%
Biontech Se Adr Stock (BNTX) Company Profile
BNTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
Biontech Se Adr Stock (BNTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-11 | 開始されました | Wells Fargo | Overweight |
2024-12-02 | 繰り返されました | BMO Capital Markets | Outperform |
2024-11-19 | 開始されました | Berenberg | Buy |
2024-11-19 | アップグレード | Evercore ISI | In-line → Outperform |
2024-11-08 | アップグレード | Goldman | Neutral → Buy |
2024-09-24 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2024-09-17 | アップグレード | Jefferies | Hold → Buy |
2024-09-16 | アップグレード | JP Morgan | Underweight → Neutral |
2024-08-07 | アップグレード | Deutsche Bank | Hold → Buy |
2024-08-02 | アップグレード | HSBC Securities | Hold → Buy |
2024-05-14 | 開始されました | Evercore ISI | In-line |
2024-02-23 | 開始されました | BMO Capital Markets | Outperform |
2024-01-05 | 開始されました | Oppenheimer | Perform |
2023-12-01 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-10-16 | ダウングレード | HSBC Securities | Buy → Hold |
2023-07-14 | 開始されました | HSBC Securities | Buy |
2023-05-17 | アップグレード | Redburn | Neutral → Buy |
2022-12-15 | アップグレード | BofA Securities | Neutral → Buy |
2022-08-17 | 開始されました | Cowen | Market Perform |
2022-07-13 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2022-07-06 | 再開されました | Canaccord Genuity | Buy |
2022-02-01 | アップグレード | Redburn | Sell → Neutral |
2021-12-16 | 開始されました | Morgan Stanley | Equal-Weight |
2021-11-10 | アップグレード | H.C. Wainwright | Neutral → Buy |
2021-10-22 | 開始されました | Deutsche Bank | Hold |
2021-10-07 | 開始されました | Jefferies | Hold |
2021-08-11 | アップグレード | Bryan Garnier | Neutral → Buy |
2021-07-19 | 再開されました | Wolfe Research | Outperform |
2021-06-16 | ダウングレード | Redburn | Neutral → Sell |
2021-05-18 | 開始されました | Goldman | Neutral |
2021-05-11 | ダウングレード | Bryan Garnier | Buy → Neutral |
2020-12-01 | ダウングレード | BofA Securities | Buy → Neutral |
2020-08-03 | 再開されました | Berenberg | Buy |
2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
2020-06-30 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-05-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-04-28 | ダウングレード | BofA/Merrill | Buy → Neutral |
2020-03-18 | ダウングレード | JP Morgan | Overweight → Neutral |
2020-03-09 | 開始されました | H.C. Wainwright | Neutral |
2020-01-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-01-22 | ダウングレード | UBS | Buy → Neutral |
2019-11-05 | 開始されました | Wolfe Research | Outperform |
2019-11-04 | 開始されました | Berenberg | Buy |
2019-11-04 | 開始されました | BofA/Merrill | Buy |
2019-11-04 | 開始されました | Canaccord Genuity | Buy |
2019-11-04 | 開始されました | JP Morgan | Overweight |
2019-11-04 | 開始されました | SVB Leerink | Outperform |
2019-11-04 | 開始されました | UBS | Buy |
すべてを表示
Biontech Se Adr (BNTX) 最新ニュース
BioNTech SE ADR falls Thursday, underperforms market - MarketWatch
BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch
3 No-Brainer Biotech Stocks to Buy With $200 Right Now - The Motley Fool
Stocks Generating Improved Relative Strength: BioNTech ADR - Investor's Business Daily
BioNTech SE ADR rises Tuesday, outperforms market - MarketWatch
BioNTech SE ADR falls Monday, underperforms market - MarketWatch
BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test - Investing.com
BioNTech SE ADR falls Friday, underperforms market - MarketWatch
BioNTech SE ADR rises Thursday, outperforms market - MarketWatch
BioNTech SE ADR rises Wednesday, outperforms market - MarketWatch
BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch
BioNTech SE ADR rises Friday, outperforms market - MarketWatch
BioNTech's SWOT analysis: mRNA pioneer's stock balances COVID legacy, oncology future - Investing.com
BioNTech SE ADR rises Monday, outperforms market - MarketWatch
Stocks Showing Improving Market Leadership: BioNTech ADR Earns 81 RS Rating - Investor's Business Daily
BioNTech ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily
BioNTech's SWOT analysis: oncology pipeline fuels stock's potential amid market volatility - Investing.com
BioNTech Stock Got A IBD RS Rating Lift - MSN
BioNTech ADR Shows Improved Relative Strength; Still Shy Of Benchmark - Inkl
Analysts Turn Bullish on BioNTech Stock Amid Volatility - Schaeffers Research
10 Biggest Biotechnology Companies - Investopedia
BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register
Powell Speaks The Truth - Benzinga
Goodwin, Conyers, A&O Shearman Act on $800M China Biotech Sale - Law.com International
BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up - Yahoo Finance
Stock Futures Quiet as Market Heads for Winning Week - Schaeffers Research
BioNTech Earnings: Strong Covid Revenue, but Full-Year Expectations Unchanged - Morningstar
BioNTech SE Reports Strong Q3 2024 Results - TipRanks
This 6%-yielding U.S. pharma giant is a safe hold - The Globe and Mail
Weekly Upgrades and Downgrades - InvestorPlace
BioNTech SE ADR outperforms market despite losses on the day - MarketWatch
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase - Yahoo Finance
Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - Nasdaq
BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - MSN
Biontech Se Adr (BNTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):